GGrantIndex
Sort

21,453 grants matching tuberculosis

Latent and Reactivation Tuberculosis

$670,886
University Of Pittsburgh At Pittsburgh · R01 · FY2004 · HL

Membrane Protein Structures and Interactions in the M. tuberculosis Divisome

$670,880
Timothy A Cross · Florida State University · R01 · FY2019 · AI

Membrane Protein Structures and Interactions in the M. tuberculosis Divisome

$670,880
Timothy A Cross · Florida State University · R01 · FY2018 · AI

Socio-spatial Networks and Tuberculosis Infection in Youth in Rural Uganda

$670,879
Carina Marquez · University Of California, San Francisco · R01 · FY2021 · AI

HIV - Emergence of Drug Resistance

$670,826
Sally Margaret Blower · University Of California Los Angeles · R01 · FY2012 · AI

TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies

$670,820
David R Boulware · University Of Minnesota · R01 · FY2022 · AI

Strategies for tuberculosis control in prisons

$670,765
Jason Randolph Andrews · Stanford University · R01 · FY2020 · AI

Evolutionary and Functional Significance of Novel Mutations in MDR-XDR TB

$670,704
Faramarz Valafar · San Diego State University · R01 · FY2020 · AI

Continuity of Care for Drug-Addicted Offenders in RI

$670,625
Rhode Island Hospital · U01 · FY2004 · DA

CAREER: A Novel Twist in Nature; Proteins with a Pierced Lasso Topology

$670,600
Ellinor B Haglund · University Of Hawaii · · FY2022 · MPS

Evolutionary and Functional Significance of Novel Mutations in MDR-XDR TB

$670,477
Faramarz Valafar · San Diego State University · R01 · FY2019 · AI

Novel methods of pharmacologic monitoring for multidrug resistant tuberculosis treatment in the setting of HIV infection

$670,213
John Zapata Metcalfe · University Of California, San Francisco · R01 · FY2020 · AI

Socio-spatial Networks and Tuberculosis Infection in Youth in Rural Uganda

$670,209
Carina Marquez · University Of California, San Francisco · R01 · FY2022 · AI

Development of a tularemia vaccine that is safer and more potent than LVS

$670,197
Marcus Aaron Horwitz · University Of California Los Angeles · R56 · FY2010 · AI

Bacterial Determinants of TB Progression

$669,878
David R Sherman · Seattle Biomedical Research Institute · U19 · FY2014 · AI

Project 4. Defining cell division pathways in Mtb.

$669,853
Sabine Ehrt · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · AI

Role of mycobacterial dynamin-like proteins in the biogenesis of membrane vesicles, and host-pathogen interactions

$669,830
Gloria Marcela Rodriguez · Rbhs-New Jersey Medical School · R01 · FY2021 · AI

Identifying Common T Cell Responses to Major Pathogens in Rhesus Macaques

$669,782
David H Oconnor · University Of Wisconsin-Madison · R24 · FY2015 · OD

Clinical

$669,770
Rajesh T Gandhi · Harvard University · P30 · FY2012 · AI

The roles of genes critical for growth in vitro

$669,700
Dirk Schnappinger · Harvard School Of Public Health · U19 · FY2016 · AI

MmpL3 as a target for novel anti-TB agents

$669,615
Mary Jackson · Colorado State University · R01 · FY2020 · AI

A randomized clinical trial of early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa

$669,513
Scott K Heysell · University Of Virginia · U01 · FY2023 · AI

Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa

$669,497
Susan E Dorman · Johns Hopkins University · R01 · FY2008 · AI

PREVINE-TB: PRevent: EValuating the implementation of NEw strategies for preventive TB among people living with HIV in Brazil

$669,384
Jonathan E Golub · Johns Hopkins University · R01 · FY2018 · AI

TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENT

$669,209
Greduvel Duran-Guzman · Puerto Rico Department Of Health · U52 · FY2013 · PS